| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/09/2003 | US20030008815 For diagnosis and therapy of immune related disease in mammals, including humans; tumor therapy |
| 01/09/2003 | US20030008814 Pseudomycin phosphate prodrugs |
| 01/09/2003 | US20030008812 Glycopeptide derivatives |
| 01/09/2003 | US20030008811 Agent for improving hepatic functions in chronic hepatitis and methods of using thereof |
| 01/09/2003 | US20030008810 Nutritional intervention composition for enhancing and extending satiety |
| 01/09/2003 | US20030008807 Novel signaling pathway for the production of inflammatory pain and neuropathy |
| 01/09/2003 | US20030008806 Inhibitors of phosphodiesterases (PDEs) such as papaverine for treatment of drug dependence and psychological disorders |
| 01/09/2003 | US20030008399 Controlling viral replication or gene expression in a cell; obtain cell infected with virus, transform with nucleotide sequence expressng preferential replicases, monitor viral gene expression |
| 01/09/2003 | US20030008398 Nucleotide sequences coding polypeptide for use in the treatment of autoimmune and inflammatory diseases |
| 01/09/2003 | US20030008391 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008390 Genetically engineered cell for use in the generation of viral vector for use in gene therapy |
| 01/09/2003 | US20030008376 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008375 Generation of preferential adenoviral expression vector; obtain cells, infect with virus, harvest and lyse cell, recover vectors |
| 01/09/2003 | US20030008370 Nucleotid sequences coding enzymatic polypeptide for use in the treatment of cancer |
| 01/09/2003 | US20030008369 Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases |
| 01/09/2003 | US20030008357 Polypeptide for use in the treatment of inflammation, rheumatoid arritis, psoriasis, and diabetic retinopathy |
| 01/09/2003 | US20030008356 Novel polypeptide, a cDNA encoding the same, and use of it |
| 01/09/2003 | US20030008354 Peptide for use in the diagnosis and treatment of parkinson's, cancer and developmental defects |
| 01/09/2003 | US20030008351 Nucleotide sequences coding polypeptide for use in the treatment of heart defects |
| 01/09/2003 | US20030008348 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030008346 MMSC1 - an MMAC1 interacting protein |
| 01/09/2003 | US20030008330 Nucleotide sequences coding polypeptides for use in the treatment and prevention of cancer and autoimmune disease |
| 01/09/2003 | US20030008311 Histone-like protein |
| 01/09/2003 | US20030008300 Amplification of nitroso compouds in erythrocytes; obtain mammal, inject with therapeutic agent, monitor concentration levels of preferential nitroso compounds |
| 01/09/2003 | US20030008299 Nucleotide sequences coding polypeptides for use in the treatment of cancer |
| 01/09/2003 | US20030008297 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030008295 Nucleic acid sensor molecules |
| 01/09/2003 | US20030008279 Cells for use in the diagnosis and treatment of viral diseases |
| 01/09/2003 | US20030008274 Nucleotide sequences coding polypeptide for use in the treatment of and prevention of viral diseases |
| 01/09/2003 | US20030008273 Methods for increasing the survival of neuronal cells |
| 01/09/2003 | US20030008019 Aqueous solution; efficient penetration |
| 01/09/2003 | US20030008018 Acrochordon alleviation |
| 01/09/2003 | US20030008016 Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system |
| 01/09/2003 | US20030008013 Administering insulin to lungs |
| 01/09/2003 | US20030008008 Fast dissolving orally consumable films |
| 01/09/2003 | US20030007992 Zero-order prolonged release coaxial implants |
| 01/09/2003 | US20030007988 Slimming cosmetic composition comprising a plant extract containing a plant natriuretic peptide (PNP) |
| 01/09/2003 | US20030007978 Quantiative analysis; genetic engineering |
| 01/09/2003 | US20030007976 Anticancer agents; sensitivity to Mycobacterium |
| 01/09/2003 | US20030007975 Anticancer agents |
| 01/09/2003 | US20030007972 Administering tumor necrosis factor inhibitor |
| 01/09/2003 | US20030007971 Interleukin inhibitor |
| 01/09/2003 | US20030007970 Using lymphotactin antagonist |
| 01/09/2003 | US20030007969 Administering integrin antagonist |
| 01/09/2003 | US20030007968 Administering bone marrow cells with lymphyocytes removed; then busulfan |
| 01/09/2003 | US20030007967 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
| 01/09/2003 | US20030007966 Adult respiratory distress syndrome |
| 01/09/2003 | US20030007965 Treatment of substance P-related disorders |
| 01/09/2003 | US20030007964 Antiinfammatory agent; autoimmune diseases |
| 01/09/2003 | US20030007963 Treatment of pompe's disease |
| 01/09/2003 | US20030007962 Pharmaceutical composition containing mosapride and pancreatin |
| 01/09/2003 | US20030007960 Oral administering of protein as protease inhibitor; rheumatic diseases |
| 01/09/2003 | US20030007959 Oral methods of treatment |
| 01/09/2003 | US20030007956 Proteins that interact with betaTrCP |
| 01/09/2003 | US20030007955 Enclosures housing cell-coated supports for treating tumors |
| 01/09/2003 | US20030007954 Cardiovascular disorder; strokes; gene therapy |
| 01/09/2003 | US20030007952 Polypeptides |
| 01/09/2003 | US20030007938 Methods for treating fingernails and toenails |
| 01/09/2003 | CA2452393A1 Hydrophobic dopamine agonists administered to the dermis |
| 01/09/2003 | CA2452364A1 Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins |
| 01/09/2003 | CA2452321A1 Enhanced pharmacokinetic profile of hydrophobic substances |
| 01/09/2003 | CA2452200A1 Method for identifying compounds that specifically deplete mast cells |
| 01/09/2003 | CA2452195A1 Identification and characterization of multiple splice variants of the mu opioid receptor gene |
| 01/09/2003 | CA2452171A1 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis |
| 01/09/2003 | CA2452082A1 Extracellular messengers |
| 01/09/2003 | CA2452069A1 Hypoglycaemic peptides and methods of use thereof |
| 01/09/2003 | CA2452043A1 The use of angiotensin i derivative as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders |
| 01/09/2003 | CA2452030A1 Sustained release pharmaceutical composition |
| 01/09/2003 | CA2451955A1 Antibodies to opgl |
| 01/09/2003 | CA2451850A1 Medicinal compositions |
| 01/09/2003 | CA2451795A1 Cell-based high-throughput screening methods |
| 01/09/2003 | CA2451711A1 Immunopotentiator for mammary gland of dairy cows containing lactoferrin as an active ingredient |
| 01/09/2003 | CA2451236A1 Peptides for use as translocation factors |
| 01/09/2003 | CA2451218A1 Diagnosis and treatment of cancer |
| 01/09/2003 | CA2450354A1 Enhanced systemic absorption of intradermally delivered substances |
| 01/09/2003 | CA2448059A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/09/2003 | CA2448020A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/09/2003 | CA2424645A1 New use of dipeptidyl peptidase iv inhibitors |
| 01/09/2003 | CA2419888A1 Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis |
| 01/09/2003 | CA2418543A1 New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 01/08/2003 | EP1273918A2 Method of selecting evolved binding members using a native epitope |
| 01/08/2003 | EP1273914A1 Hypotensors |
| 01/08/2003 | EP1273667A1 High throughput identification of modulators of angiogenesis |
| 01/08/2003 | EP1273660A2 Human sodium-hydrogen exchanger like protein 1 |
| 01/08/2003 | EP1273659A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/08/2003 | EP1273658A1 Novel protein, dna thereof and process for producing the same |
| 01/08/2003 | EP1273657A1 Novel protein, process for producing the same and use thereof |
| 01/08/2003 | EP1273656A1 Use of inhibitors of expression or activity of p8/com1 for treating tumours |
| 01/08/2003 | EP1273592A2 Process for the purification of pharmacologically active proteins through cationic exchange chromatography |
| 01/08/2003 | EP1273308A1 Peptide-flavonoid conjugates, their preparation and use in uv protection |
| 01/08/2003 | EP1273306A1 Powdery preparation for transmucosal administration containing a polymeric form of drug and exhibiting improved storage stability |
| 01/08/2003 | EP1273305A1 Medical preparation for inhalation comprising Antithrombin for treating inflammatory lung diseases and ARDS |
| 01/08/2003 | EP1273304A2 Use of interleukin-15 |
| 01/08/2003 | EP1273303A1 Pharmaceutical composition comprising a mixture of at least two rBMPs and the use thereof in the treatment of orthopaedic and dental patients |
| 01/08/2003 | EP1273298A2 Ritonavir in combination with an additional HIV protease inhibitor for treating aids |
| 01/08/2003 | EP1273289A1 Pharmaceutical compositions containing ascomycin derivatives |
| 01/08/2003 | EP1273288A1 Pharmaceutical compositions containing rapamycin derivatives |
| 01/08/2003 | EP1273239A1 Composition comprising partly-hydrolyzed fish gelatin and use thereof. |
| 01/08/2003 | EP1272666A1 A functional assay of high-density lipoprotein |
| 01/08/2003 | EP1272665A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |